Wyeth Hit With Securities Suit Over Menopause Drug

Law360, New York (November 15, 2007, 12:00 AM EST) -- Wyeth has been slammed by a proposed shareholder class action alleging that the pharmaceuticals giant made false and misleading statements about its depression and menopause drug Pristiq.

The law firm Coughlin, Stoia, Geller, Rudman & Robbins LLP announced on Wednesday that it had lodged the lawsuit in the U.S. District Court in Manhattan, accusing Wyeth of hiding negative data about Pristiq's effects when it filed a New Drug Application in June 2006.

A spokesman for Wyeth declined to comment.

The lawsuit was filed on behalf of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.